| Cancer-related molecular mechanisms research | Lifetime | 32 | CN 11 | 99.75 |
| MicroRNA in disease regulation | Lifetime | 57 | CN 13 | 99.68 |
| Berberine and alkaloids research | Lifetime | 4 | CN 1 | 99.62 |
| Circular RNAs in diseases | Lifetime | 27 | CN 13 | 99.62 |
| Ferroptosis and cancer prognosis | Lifetime | 47 | CN 14 | 99.09 |
| RNA modifications and cancer | Lifetime | 273 | CN 26 | 99.34 |
| Autophagy in Disease and Therapy | Lifetime | 123 | CN 15 | 99.09 |
| Extracellular vesicles in disease | Lifetime | 138 | CN 32 | 98.43 |
| Epigenetics and DNA Methylation | Lifetime | 514 | CN 33 | 98.73 |
| Cancer Mechanisms and Therapy | Lifetime | 149 | CN 16 | 98.34 |
| Immune cells in cancer | Lifetime | 338 | CN 32 | 98.04 |
| Flavonoids in Medical Research | Lifetime | 41 | CN 17 | 97.29 |
| Traditional Chinese Medicine Analysis | Lifetime | 140 | CN 112 | 97.74 |
| Pharmacological Effects of Natural Compounds | Lifetime | 428 | CN 118 | 97.13 |
| Cancer-related gene regulation | Lifetime | 556 | CN 68 | 97.40 |
| Gut microbiota and health | Lifetime | 792 | CN 95 | 97.58 |
| Traditional Chinese Medicine Studies | Lifetime | 218 | CN 148 | 94.82 |
| Ginseng Biological Effects and Applications | Lifetime | 270 | CN 138 | 95.61 |
| Kruppel-like factors research | Lifetime | 232 | CN 23 | 95.36 |
| Histone Deacetylase Inhibitors Research | Lifetime | 592 | CN 58 | 94.98 |
| Drug-Induced Hepatotoxicity and Protection | Lifetime | 719 | CN 43 | 95.37 |
| Plant-based Medicinal Research | Lifetime | 301 | CN 86 | 94.34 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 957 | CN 119 | 93.17 |
| Andrographolide Research and Applications | Lifetime | 147 | CN 38 | 81.27 |
| Biological and pharmacological studies of plants | Lifetime | 563 | CN 271 | 79.58 |
| Medicinal Plant Pharmacodynamics Research | Lifetime | 630 | CN 419 | 74.74 |
| Medicinal plant effects and applications | Lifetime | 747 | CN 116 | 77.36 |
| Natural Compounds in Disease Treatment | Lifetime | 481 | CN 243 | 74.89 |
| Phytochemistry and biological activity of medicinal plants | Lifetime | 847 | CN 229 | 74.06 |
| Medicinal Plants and Bioactive Compounds | Lifetime | 914 | CN 294 | 73.22 |
| Saffron Plant Research Studies | Lifetime | 603 | CN 85 | 71.15 |
| Mangiferin and Mango Extracts | Lifetime | 576 | CN 82 | 41.17 |
| Epigenetics and DNA Methylation | 2021-2025 | 6 | CN 3 | 99.61 |
| Cancer-related molecular mechanisms research | 2021-2025 | 10 | CN 7 | 99.87 |
| RNA modifications and cancer | 2021-2025 | 14 | CN 8 | 99.83 |
| MicroRNA in disease regulation | 2021-2025 | 25 | CN 14 | 99.52 |
| Ferroptosis and cancer prognosis | 2021-2025 | 42 | CN 31 | 99.14 |
| Immune cells in cancer | 2021-2025 | 47 | CN 25 | 98.64 |
| Autophagy in Disease and Therapy | 2021-2025 | 30 | CN 14 | 98.19 |
| Gut microbiota and health | 2021-2025 | 134 | CN 69 | 98.70 |
| Traditional Chinese Medicine Analysis | 2021-2025 | 15 | CN 13 | 97.95 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 48 | CN 11 | 96.26 |
| RNA Research and Splicing | 2021-2025 | 155 | CN 49 | 95.68 |
| Extracellular vesicles in disease | 2021-2025 | 183 | CN 111 | 96.61 |
| Circular RNAs in diseases | 2021-2025 | 120 | CN 88 | 97.01 |
| Cancer-related gene regulation | 2021-2025 | 79 | CN 51 | 94.85 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 59 | CN 20 | 95.06 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 207 | CN 93 | 94.71 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 262 | CN 84 | 95.14 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 874 | CN 191 | 96.61 |
| CRISPR and Genetic Engineering | 2021-2025 | 459 | CN 186 | 92.80 |
| Adipose Tissue and Metabolism | 2021-2025 | 433 | CN 92 | 91.97 |
| Ubiquitin and proteasome pathways | 2021-2025 | 271 | CN 121 | 91.13 |
| Diet and metabolism studies | 2021-2025 | 847 | CN 108 | 92.97 |
| Pharmacological Effects of Natural Compounds | 2021-2025 | 233 | CN 140 | 90.63 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 375 | CN 133 | 91.12 |
| Natural product bioactivities and synthesis | 2021-2025 | 410 | CN 187 | 88.02 |
| Neuroscience of respiration and sleep | 2021-2025 | 396 | CN 25 | 90.21 |
| Food composition and properties | 2021-2025 | 635 | CN 349 | 92.11 |
| Ginseng Biological Effects and Applications | 2021-2025 | 176 | CN 147 | 87.86 |
| Colorectal Cancer Treatments and Studies | 2021-2025 | 837 | CN 111 | 90.38 |
| Lipid metabolism and disorders | 2021-2025 | 174 | CN 30 | 84.64 |
| Cancer Cells and Metastasis | 2021-2025 | 869 | CN 188 | 84.62 |
| Berberine and alkaloids research | 2021-2025 | 76 | CN 39 | 83.05 |
| Plant-based Medicinal Research | 2021-2025 | 86 | CN 64 | 81.66 |
| DNA Repair Mechanisms | 2021-2025 | 659 | CN 91 | 82.58 |
| interferon and immune responses | 2021-2025 | 922 | CN 505 | 80.69 |
| Traditional Chinese Medicine Studies | 2021-2025 | 194 | CN 142 | 80.43 |
| Andrographolide Research and Applications | 2021-2025 | 33 | CN 8 | 74.65 |
| Toxin Mechanisms and Immunotoxins | 2021-2025 | 251 | CN 33 | 77.25 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 724 | CN 144 | 78.94 |
| Diabetic Foot Ulcer Assessment and Management | 2021-2025 | 948 | CN 158 | 77.48 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 628 | CN 189 | 72.46 |
| Cancer Mechanisms and Therapy | 2021-2025 | 827 | CN 368 | 73.73 |
| Fatty Acid Research and Health | 2021-2025 | 787 | CN 158 | 70.49 |
| Medicinal plant effects and applications | 2021-2025 | 124 | CN 48 | 71.39 |
| Chemotherapy-induced cardiotoxicity and mitigation | 2021-2025 | 893 | CN 89 | 69.12 |
| Biomarkers in Disease Mechanisms | 2021-2025 | 267 | CN 106 | 67.75 |
| Kruppel-like factors research | 2021-2025 | 423 | CN 159 | 65.36 |
| Biological and pharmacological studies of plants | 2021-2025 | 399 | CN 324 | 57.34 |
| Ideological and Political Education | 2021-2025 | 130 | CN 106 | 55.43 |
| Calcium signaling and nucleotide metabolism | 2021-2025 | 590 | CN 114 | 47.36 |
